We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
-4.12%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$166M
AUM Growth
-$9.35M
Cap. Flow
-$493K
Cap. Flow %
-0.3%
Top 10 Hldgs %
39.09%
Holding
105
New
3
Increased
15
Reduced
30
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 22.09%
2 Healthcare 18.04%
3 Industrials 17.47%
4 Financials 14.86%
5 Consumer Staples 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
101
Citigroup
C
$222B
-13,039
Closed -$600K
CBU icon
102
Community Bank
CBU
$3.53B
-4,664
Closed -$219K
EW icon
103
Edwards Lifesciences
EW
$47.6B
-1,150
Closed -$108K
WMT icon
104
Walmart Inc
WMT
$871B
-660
Closed -$35K

Similar funds

Lipe & Dalton's Q3 2023 Portfolio in Review

As of Q3 2023, Lipe & Dalton held 105 positions worth $166M, down 5.3% from $176M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Lipe & Dalton's Q3 2023 filing shows 3 new, 15 increased, 30 reduced and 5 closed positions. Its largest new stake was Intercontinental Exchange: 3,460 shares worth $381K. The largest sale was Citigroup, an estimated $600K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Lipe & Dalton's largest Q3 2023 buy was Intercontinental Exchange: 3,460 shares worth $381K.
  • Lipe & Dalton added most to Charles Schwab in Q3 2023, an estimated $467K increase.
  • Lipe & Dalton's biggest Q3 2023 reduction was TE Connectivity, cutting an estimated $140K.
  • Lipe & Dalton fully exited Citigroup in Q3 2023, selling an estimated $600K.
  • Lipe & Dalton's ten largest holdings make up 39% of its $166M portfolio in Q3 2023.
  • Lipe & Dalton opened 3 new positions and closed 5 in Q3 2023.
  • Lipe & Dalton's portfolio value fell 5.3% quarter-over-quarter to $166M.

Based on Lipe & Dalton's 13F filing for Q3 2023, filed 3 Nov 2023.